Should Dividend Investors Add This Stock to Their Portfolios?

·4 min read
Should Dividend Investors Add This Stock to Their Portfolios?

With 50 consecutive years of dividend growth, healthcare giant Abbott Laboratories (NYSE: ABT) is a Dividend King. In late July, Abbott Laboratories shared its financial results for the second quarter ended June 30. As was also the case in the previous quarter, Abbott's nutrition segment was the only segment to not log year-over-year sales growth.